These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25529455)

  • 21. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
    Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
    Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34).
    Kneissel M; Boyde A; Gasser JA
    Bone; 2001 Mar; 28(3):237-50. PubMed ID: 11248653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
    Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL
    J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.
    Miyakoshi N
    Curr Pharm Des; 2004; 10(21):2615-27. PubMed ID: 15320749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.
    Ejersted C; Andreassen TT; Oxlund H; Jørgensen PH; Bak B; Häggblad J; Tørring O; Nilsson MH
    J Bone Miner Res; 1993 Sep; 8(9):1097-101. PubMed ID: 8237479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L; Quarles LD; Spurney RF
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats.
    Gabet Y; Kohavi D; Müller R; Chorev M; Bab I
    Osteoporos Int; 2005 Nov; 16(11):1436-43. PubMed ID: 15812598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise does not enhance aged bone's impaired response to artificial loading in C57Bl/6 mice.
    Meakin LB; Udeh C; Galea GL; Lanyon LE; Price JS
    Bone; 2015 Dec; 81():47-52. PubMed ID: 26142929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
    Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
    Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical thickness adaptation to combined mechanical loading and parathyroid hormone treatments is site specific and synergistic in the mouse tibia model.
    Miller CJ; Trichilo S; Pickering E; Martelli S; Dall'Ara E; Delisser P; Meakin LB; Pivonka P
    Bone; 2024 Mar; 180():116994. PubMed ID: 38135023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits.
    Mashiba T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    Bone; 2001 May; 28(5):538-47. PubMed ID: 11344054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats.
    Gera I; Hock JM; Gunness-Hey M; Fonseca J; Raisz LG
    Calcif Tissue Int; 1987 Apr; 40(4):206-11. PubMed ID: 3107773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB/c mice.
    Gohin S; Carriero A; Chenu C; Pitsillides AA; Arnett TR; Marenzana M
    Cell Biochem Funct; 2016 Mar; 34(2):52-62. PubMed ID: 26834008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
    Green J; Goldberg R; Maor G
    Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.
    Hock JM; Gera I; Fonseca J; Raisz LG
    Endocrinology; 1988 Jun; 122(6):2899-904. PubMed ID: 3371266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.